Delivery Order SPE2DB24D2105-SPE2DB25FAQAJ
- Not listed
- The Defense Logistics Agency awarded a $1,135.05 delivery order to AmerisourceBergen Drug Corp for TENIVAC syringes (0.5 mL) under a firm fixed price contract type. The order was competitively awarded without a set-aside designation and is scheduled for completion by August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this delivery order, which represents a child contract under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tenivac syringes (0.5ML) under a firm fixed-price contract with a ceiling value of $2,331.12. This non-set-aside award was issued on June 24, 2025, with an ultimate completion date of June 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $4,086.18 to AmerisourceBergen Drug Corp for TENIVAC syringes (0.5ML) with a completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,362.06 for 0.5mL Tenivac syringes on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement that runs through December 2026. The syringes will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,270.10 to AmerisourceBergen Drug Corp for the supply of Tenivac syringes (0.5ML) under a competitive, non-set-aside procurement. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and operates on a firm fixed price basis. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Tenivac syringes (0.5ml) under a firm fixed-price contract valued at $1,816.08. The order represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Tenivac syringes (0.5mL) with a ceiling value of $1,571.09. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tenivac syringes (0.5mL) valued at $1,135.05 on July 29, 2025, with a completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,362.06 by the Defense Logistics Agency on August 12, 2025, for the supply of Tenivac syringes in 0.5 mL quantities. The contract is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-competitive set-aside award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,929.40 to AmerisourceBergen Drug Corp for the supply of Tenivac syringes in 0.5mL quantities. This competitively awarded, firm fixed price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQAJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TENIVAC syringes (0.5mL) under a firm fixed-price contract valued at $6,779.54. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of August 8, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this order. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen maintains a significant role in the federal medical supply chain, serving customers including the Defense Health Agency and U.S. Coast Guard through competitively awarded delivery orders with firm fixed pricing across various therapeutic domains and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 8/7/25 |